Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Clinical trial NCT02071888 · COMPLETED

Trial details

NCT number: NCT02071888
Sponsor: Calithera Biosciences, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma (NHL)Multiple Myeloma Waldenstrom's Macroglobulinemia (WM)Other B-cell NHL Subtypes, Including WM T-cell NHL

Start date: 2014-02-01
Primary completion: 2016-04-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.